Vasileios Zavvos NEPHROLOGIST Consultant, Nephrology Centre (Centre for Diagnosis, Treatment & Research on Kidney Diseases)

University of Patras, School of Medicine
TITLE: Functional and morphological alterations of the peritoneum under the effect of lactate and bicarbonate-based peritoneal dialysis solutions – Proteomic analysis of the peritoneal effluent for the identifications of biomarkers of peritoneal fibrosis and encapsulating peritoneal sclerosis

1. Member of the Hellenic Society of Nephrology
2. Member of the European Renal Association – ERA-EDTA (ID: 16503)
3. Sentinel Reader & Rater in Nephrology, 2018
   Health Information Research Unit – McMaster Online Rating of Evidence (MORE) System, McMaster University, Hamilton, Ontario, Canada
4. Peer reviewer
   Nephrology Dialysis Transplantation, 2018

• 5/2019: Nephrologist, Centre for Diagnosis, Treatment & Research on Kidney Diseases. Hygeia Hospital, Athens, Greece
• 2017 – 2019: Locum Consultant Nephrologist, Centre for Nephrology
  “G. Papadakis”, Nikaia – Pireaus General Hospital, Athens, Greece
• 2016 – 2017: Research Fellow. ERA-EDTA Young Fellowship Programme, in collaboration with the Hellenic Society of Nephrology and the Stavros Niarchos Foundation, Cardiff University, Department of Nephrology & Wales Kidney Research Unit, Cardiff, United Kingdom
• 2011 – 2015: Specialty Registrar in Nephrology, Department of Nephrology, University Hospital of Patras, Patras, Greece
• 2014: Clinical Observer, Cardiff University, University Hospital of Wales, Department of Nephrology, Cardiff, United Kingdom
• 2011: Research Fellow, University of Sheffield, Sheffield Kidney Institute, Academic Unit of Nephrology, Sheffield, United Kingdom
• 2007 – 2009: Resident doctor in Internal Medicine, 2^nd Department of Internal Medicine, “Vostanio” General Hospital of Mytilene, Mytilene, Greece
• 2006 – 2007: Medical Doctor, Hellenic Army, Medical Corps

Clinical Work/Experience:

In all disciplines of Nephrology (Clinical Nephrology, Hemodialysis, Peritoneal Dialysis, Renal Transplantation), as I have worked as a trainee, post-specialty fellow and specialist in Departments and Hospitals that are among the largest in their countries and treat large numbers of patients across the whole spectrum of Nephrology.

Educational Experience , Invited Lectures: 

• Nephrology Registrars’ clinical training in the Department of Nephrology of Nikaia-Piraeus General Hospital, as part of my duties as locum consultant nephrologist and, more recently, with participation / lecture in the training seminar of the Hellenic Society of Nephrology.
• Peritoneal dialysis solutions. 30^th Scientific Meeting of the Hellenic Nursing Society of Nephrology, Athens, 2019
• Peritonitis in Peritoneal dialysis: Past, Present & Future. 28^th Annual Seminar of the Department of Nephrology, “Red Cross – Korgialeneio-Mpenakeio General Hospital, Athens, 2019
• Peritoneal Dialysis Techniques and Apparatus. 12^th Educational Seminar in Nephrology, Thessaloniki, 2018
• Acid-base disorders: Clinical Scenarios. 44^th Panhellenic Medical Congress, Athens, 2018
• Peritoneal Eflluent Biomarkers and assessment of the functional and morphological changes of the peritoneal membrane. 2^nd Educational Seminar in Peritoneal Dialysis, Heraklion, 2015
• The role of proteomics in the timely recognition of encapsulating peritoneal sclerosis. Xth Kytherean Days of Hypertension & Nephrology, Kythera, 2014

Clinical Interests:

• Renal Replacement Therapies, with interest in peritoneal dialysis
• Clinical Nephrology

Research Interests:

• Clinical, Epidemiological and Translational Research in Hemodialysis and Peritoneal Dialysis, with interest in biomarkers and risk factors for peritoneal fibrosis and cardiovascular disease

1. Award for the best research communication Proteomic analysis of peritoneal effluent
   Zavvos V., Savvidaki Ε., Kehagias I., Johnson TS., Goumenos D.
   17^th Panhellenic Congress of Nephrology, 2012, Kyllini, Greece
2. Award for the best research communication   Long-Term Use of Cinacalcet in Kidney Transplant Recipients With Hypercalcemic Secondary Hyperparathyroidism.
   Zavvos V., Savvidaki E., Papachristou E., Kalliakmani P., Karavias D., Goumenos D.
   17^th Panhellenic Congress of Transplantation, 2013, Athens, Greece
3. Organizing Committee Award Intraperitoneal inflammation increases with time on peritoneal dialysis and is associated with increasing plasma IL-6, predicting worse survival: Results from the GLOBAL Fluid Study.
   EH. Elphick, V. Zavvos, N. Topley, JA. Chess, YL. Kim, JY. Do, HB. Lee, SN. Davison, M., Dorval, SJ. Davies, D. Fraser, M. Lambie.
   20th Panhellenic Congress of Nephrology, May 2018, Athens, Greece
4. Research Fellowship. ERA-EDTA Young Fellowhsip Programme, in collaboration with the Hellenic Society of Nephrology and the Stavros Niarchos Foundation
   7/2016 – 7/2017: Cardiff University, Department of Nephrology & Wales Kidney Research Unit, Cardiff, United Kingdom

“Harrison’s Nephrology and Acid-Base Disorders”, Greek Edition
Editor: Professor DS Goumenos, Parisianou S.A. Publishing House, copyright 2013

1. Long-Term Use of Cinacalcet in Kidney Transplant Recipients With Hypercalcemic Secondary Hyperparathyroidism: A Single-Center Prospective Study.
   Zavvos V, Fyssa L, Papasotiriou M, Papachristou E, Ntrinias T, Savvidaki E, Goumenos DS.
   Exp Clin Transplant. 2018 Jun;16(3):287-293. doi: 10.6002/ect.2016.0342.
   Impact Factor (2017): 0.695

2. The Authors Reply. Comment on: Fetuin-A in the peritoneal effluent of patients with encapsulating peritoneal sclerosis-more than a protein?
   Zavvos V, Davies SJ, Topley N, Johnson TS.
   Kidney Int. 2017 Nov;92(5):1290. doi: 10.1016/j.kint.2017.08.012.
   Impact Factor (2017): 8.429

3. A prospective, proteomics study identified potential biomarkers of encapsulating peritoneal sclerosis in peritoneal effluent.
   Zavvos V, Buxton AT, Evans C, Lambie M, Davies SJ, Topley N, Wilkie M, Summers A, Brenchley P, Goumenos DS, Johnson TS.
   Kidney Int. 2017 Oct;92(4):988-1002. doi: 10.1016/j.kint.2017.03.030.
   Impact Factor (2017): 8.429

4. Vanishing leg ulcers.
   Moris D, Zavvos V, Zavos G.
   Surgery. 2017 Nov;162(5):1181-1182. doi: 10.1016/j.surg.2016.12.006.
   Impact Factor (2017): 3.574

5. De Novo Visceral Malignancies in Renal Transplant Recipients: A Single Center Experience of 2054 Recipients for More Than 30 Years.
   Zavos G, Moris D, Kostakis ID, Vernadakis S, Bokos J, Zavvos V, Lionaki S, Boletis J.
   Exp Clin Transplant. 2015 Aug;13(4):313-8.
   Impact Factor (2017): 0.695

6. Incidence and management of Kaposi sarcoma in renal transplant recipients: the Greek experience.
   Zavos G, Moris D, Vernadakis S, Bokos J, Lionaki S, Mamarelis G, Panagiotellis K, Zavvos V, Boletis I.
   Transplant Proc. 2014 Nov;46(9):3199-202. doi: 10.1016/j.transproceed.2014.09.165.
   Impact Factor (2017): 0.806

8. Parameters influencing blood erythropoietin levels of renal transplant recipients during the early post-transplantation period.
   Kalantzi M, Kalliakmani P, Papachristou E, Papasotiriou M, Savvidaki E, Zavvos V, Karavias D, Goumenos DS, Vlachojannis JG.
   Transplant Proc. 2014 Nov;46(9):3179-82. doi: 10.1016/j.transproceed.2014.10.035.
   Impact Factor (2017): 0.806
9. Replacement of mycophenolate acid with everolimus in patients who became neutropenic after renal transplant.
   Savvidaki E, Kazakopoulos P, Papachristou E, Karavias D, Zavvos V, Voliotis G, Kalliakmani P, Marangos M, Goumenos DS.
   Exp Clin Transplant. 2014 Feb;12(1):31-6.
   Impact Factor (2017): 0.695

9. An uncommon presentation of non-Hodgkin’s lymphoma in a renal transplant recipient.
   Moris D, Vernadakis S, Zavvos V, Zavos G.
   Transplantation. 2013 May 27;95(10):e66-7. doi: 10.1097/TP.0b013e3182907056.
   Impact Factor (2017): 3.96

10. Multiple bilateral oncocytomas of the native kidneys following renal transplantation: report of a rare case and review of the literature.
    Vernadakis S, Karaolanis G, Moris D, Zavvos V, Liapis G, Zavos G.
    World J Surg Oncol. 2013 May 30;11:119. doi: 10.1186/1477-7819-11-119.
    Impact Factor (2017): 1.792